3 Key Research Findings from Fact.MR's Report on Automated Breas - Fox29 WFLX TV, West Palm Beach, FL-news & weather

3 Key Research Findings from Fact.MR's Report on Automated Breast Ultrasound System Market during 2018 – 2027

“Fact.MR”
Breast mammography has gained popularity as the standard diagnostic screening tool in the women’s healthcare, aiding detection and intervention of breast cancers in early stages.

A recently compiled report of Fact.MR envisages the global market for automated breast ultrasound system to record a value CAGR of 9.3% over the period of forecast, 2018 to 2027. Over 1,800 units of automated breast ultrasound systems are foreseen to be sold worldwide by 2027-end.

 

ABUS gaining Competitive Edge over HHUS

 

Breast cancer has prevailed as most commonly diagnosed cancer type, and has become the second leading cause of mortality among women, according to statistics unveiled by National Breast Cancer Foundation. With growing awareness about breast cancer, number of screening procedures has proliferated, thereby propelling demand for advanced diagnostic and follow-up care technologies such as automated breast ultrasound systems in diagnostic centers and hospitals. Facilitated screening of denser breast’s tissues, along with the provision of superior image quality, has offered automated breast ultrasound system (ABUS) a competitive edge over the handheld ultrasound system (HHUS).

 

Request Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=585

 

As automated breast ultrasound system are approved by the FDA for screening in coordination with mammography, in case of women with denser breast tissues, radiologists are increasingly opting for the technology. On the back of high quality 3D images offered by ABUS, surgeons are employing the system for pre-operative breast evaluation to identify tumor size and location accurately. However, high cost, and lack of skilled radiologists needed for ABUS have made surgeons to opt for HHUS for pre-operative evaluation.

 

Governments across the globe are launching awareness campaigns for encouraging women with breast cancer to take professional help and undergo diagnosis. Public Health England, for example, launched a campaign – Be Clear on Cancer’ in 2015 for raising awareness on breast cancer among women over seventy years old. In addition, the Breast Cancer Now Catalyst Programme encouraged and offered tremendous support to research and development in diagnosis and treatment of breast cancer.  Awareness campaigns on breast cancer are further expected to influence demand for automated breast ultrasound system.

 

Key Takeaways from Fact.MR’s Report on Automated Breast Ultrasound System Market

 

1-  North America will continue to account for bulk share of the global automated breast ultrasound system market. The U.S. is expected to remain the most lucrative country for the market growth in North America, on account of growing breast cancer prevalence and adoption of advanced screening technologies. Presence of leading market participants, favorable government initiatives, and reimbursement scenario are key growth determinants for automated breast ultrasound system market in North America.

 

To know more about Automated Breast Ultrasound System Market Trends, check the link – https://www.factmr.com/report/585/automated-breast-ultrasound-system-market

 

2-  Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for automated breast ultrasound system through 2027. Revenues from the market in Europe will remain comparatively larger than those from APEJ, and lower than those from North America.

 

3-  On the basis of care type, Hospitals will continue to spearhead the global automated breast ultrasound system market, in terms of revenues. However, revenues from care provided by diagnostic centers will increase at a relatively higher CAGR through 2027.

 

Leading players in the global automated breast ultrasound system market have been following a strategic inorganic expansion roadmap. GE Healthcare, for instance, acquired U-Systems, Inc., for expanding its portfolio of breast care innovations. Philips and SonoCine, Inc., entered into a partnership for making developments in ABUS imaging. Acquisitions and partnership activities among market players have significantly influenced development of automated breast ultrasound system. Key market players profiled by Fact.MR’s report are SonoCine Inc., Koninklijke Philips N.V., Hitachi, Ltd., Siemens AG, Delphinus Medical Technologies, Inc., and GE Healthcare.

 

Buy this Report- https://www.factmr.com/checkout/585/S

 

About Fact.MR

 

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

 

Contact Us

 

Fact.MR

 

11140 Rockville Pike

 

Suite 400

 

Rockville, MD 20852

 

United States

 

Email: sales@factmr.com

 

Web: https://www.factmr.com/

Media Contact
Company Name: Fact.MR
Contact Person: Nicholas Maze
Email: Send Email
Phone: +353-1-6111-593
Country: Ireland
Website: www.factmr.com/report/585/automated-breast-ultrasound-system-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: 3 Key Research Findings from Fact.MR’s Report on Automated Breast Ultrasound System Market during 2018 – 2027

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

Powered by Frankly

1100 Banyan Blvd.
West Palm Beach, FL 33401

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2018 Raycom Media. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.